← SynDRA
MACIMORELIN
SynDRA canonical compound SYN0001128 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | GHSR |
|---|
| Mechanism of action | ghrelin receptor agonist |
|---|
| Indication | cachexia |
|---|
| Disease area | endocrinology |
|---|
All known targets
Mechanisms of action (all sources)
- GHSR AGONIST
- Ghrelin receptor agonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- OPRM1
- ACHE
- ADORA1
- SLC6A4
- SLC6A3
- SLC6A2
- PTGS1
- PGR
- PDE4A
- PDE3A
- MAOA
- HTR2B
- HTR1A
- HRH3
- F2
- ESR1
- DRD3
- DRD1
- CHRM2
- CHRM1
- AR
- ADRA2A
- ADRA1A
- TBXA2R
Drug classes
- Growth Hormone Secretagogue Receptor Agonist
- Growth Hormone Secretagogue Receptor Agonists
ATC classes
- V04C · OTHER DIAGNOSTIC AGENTS
Cross-references
Synonyms
- MACRILEN
- Macimoreline
- Macimorelina
- ARD 07
- AEZS-130
- ARD07
- EP-01572
- EP 1572
- EP01572
- EP1572
- JMV-1843
- Macrilen
- Solorel
- ARD-07
- ARD-0705
- EP-1572
- D-87575
- AEZS 130
- JMV 1843
- macimorelina
- macimoreline
- JMV1843
- Aminoisobutyryl-tryptophyl-tryptophanamine-formyl
- macimorelinum
- RefChem:58627
- V04CD06
- DTXCID101527696
- Macimorelin [USAN:INN]
- UNII-8680B21W73
- Macimorelin (USAN)
- MACIMORELIN [USAN]
- Macimorelin [INN]
- EP 1572; JMV 1843; Macimorelin
- Aib-DTrp-DgTrp-CHO
- MACIMORELIN [MI]
- AEZS130
- MACIMORELIN [WHO-DD]
- GTPL9745
- SCHEMBL1984708
Look up MACIMORELIN in the interactive SynDRA portal →